Dr. Jonathan King
I graduated in pharmacology and in veterinary science from the University of Bristol, UK. After an internship, I studied for a PhD in equine gastroenterology at the Royal Veterinary College, London, UK.
For the past 27 years, I have been employed in industry (Ciba-Geigy, Novartis and lately Elanco Animal Health) working on the evaluation and development of pharmaceuticals for companion animals. My main research activities have included clinical pharmacology and field studies with the ACE inhibitor benazepril, the TCA clomipramine and the NSAID robenacoxib in cats and dogs.